Previous studies have reported associations between AR/ER ≥ 2.0 with poorer clinical features like positive lymph nodes, larger tumor sizes, higher histological grades and overexpression/amplification of the HER2 gene in ER+ BC patient20,21,40. The gene discussed is ERBB2; the disease is breast cancer.